Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: Systematic review and meta-analysis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 10, 2011, Pages 333-344

  Wojciechowski, Piotr ^a   Ryś, Przemysław ^a   Lipowska, Anna ^b,c   Gawȩska, Magdalena ^a   Małecki, Maciej T ^c,d  

^a HTA CONSULTING   (Poland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Continuous glucose monitoring; Meta analysis; Systematic review; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; BLOOD GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; SELF MONITORING; SYSTEMATIC REVIEW;

EID: 80455128912     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1087     Document Type: Article

References (41)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-986.
2. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ. 2006; 333: 475-480. (Pubitemid 44343444)
3. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2009; 33 Supp 1: S11-S61.
4. Melki V, Ayon F, Fernandez M, Hanaire-Broutin H. Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. Diabetes Metab. 2006; 32: 123-129.
5. Vaddiraju S, Burgess DJ, Tomazos I, et al. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol. 2010; 4: 1540-1562.
6. Medtronic MiniMed. History. http://www.minimed.com/about/ history.html. Accessed June 22, 2011.
7. Summary of safety and effectiveness data for the MiniMed Continuous Glucose Monitoring System (CGMS). PMA P980 022, Food and Drug Administration [article online], 1999. http:// www.accessdata.fda.gov/ cdrh-docs/pdf/ P980022b.pdf. Accessed June 22, 2011.
8. Block JM. Continuous glucose monitoring: changing diabetes behavior in real time and retrospectively. J Diabetes Sci Technol. 2008; 2: 484-489.
9. Hoeks LB, Greven WL, de Valk HW. Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review. Diabet Med. 2011; 28: 386-394.
10. Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009; 32: 2245-2250.
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1-12. (Pubitemid 26120810)
12. Cohen J. The Effect Size Index: d. In: Cohen J, ed. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates; 1988: 20-26.
13. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.
14. British Society for Paediatric Endocrinology and Diabetes. Continuous glucose monitoring: consensus statement on the use of glucose sensing in outpatient clinical diabetes care. http:// www.bsped.org.uk /professional/ guidelines/docs/ContinuousGlucoseMonitoring.pdf. Accessed July 12, 2011.
15. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, eds. Introduction to Meta-Analysis. Chichester, United Kingdom: John Wiley & Sons, Ltd; 2009.
16. Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics. 2001; 107: 222-226. (Pubitemid 32121233)
17. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003; 26: 1153-1157. (Pubitemid 36929264)
18. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003; 111: 933-938. (Pubitemid 36542603)
19. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2006; 114: 63-67.
20. Lagarde WH, Barrows FP, Davenport ML, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes. 2006; 7: 159-164.
21. Yates K, Hasnat Milton A, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care. 2006; 29: 1512-1517. (Pubitemid 44127573)
22. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006; 29: 2730-2732. (Pubitemid 44912209)
23. JDRF CGM Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008; 10: 310-321.
24. Hirsch IB, Abelseth J, Bode BW, et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008; 10: 377-383.
25. Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359: 1464-1476.
26. O'Connell MA, Donath S, O'Neal DN, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009; 52: 1250-1257.
27. Beck RW, Hirsch IB, Laffel L, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009; 32: 1378-1383.
28. Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, et al. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab. 2009; 35: 312-318.
29. Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34: 795-800.
30. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002; 287: 2563-2569.
31. Unger J, Parkin C. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance. Postgrad Med. 2011; 123: 81-91.
32. Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011; 34: 1723-1728.
33. Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract. 2010; 16: 730-745.
34. Block J. Prospective vs retrospective CGM - clinical application and utility. 40th Annual Meeting of the EASD; 2005; Athens.
35. Langendam MW, Hooft L, De Vries H, et al. Continuous glucose monitoring systems for type 1 diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews. 2009; 4 (CD008 101):
36. Burge MR, Mitchell S, Sawyer A, et al. Continuous glucose monitoring: the future of diabetes management. Diabetes Spectr. 2008; 21: 112-119. (Pubitemid 351792954)
37. Cemeroglu AP, Stone R, Kleis L, et al. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit. Pediatr Diabetes. 2010; 11: 182-187.
38. Kubiak T, Wörle B, Kuhr B, et al. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. Diabetes Technol Ther. 2006; 8: 570-575. (Pubitemid 44946881)
39. Golicki DT, Golicka D, Groele L, Pankowska E. Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2008; 51: 233-240.
40. Gandhi GY, Kovalaske M, Kudva Y, et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011, 5: 952-965.
41. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011; 343: d3805.